62838 Federal Register / Vol. 75, No. 197 / Wednesday, October 13, 2010 / Notices 

White Oak Bldg. 32, rm. 3300, 10903 

New Hampshire Ave., Silver Spring, MD 

20993, 301–796–8318, FAX: 301–595– 

5058, e-mail: 

Katherine.Bond@fda.hhs.gov. 

Grants Contact: Kimberly Pendleton, 

Division of Acquisition and Grants, 

Food and Drug Administration, 5630 

Fishers Lane (HFA–500), Rm. 2104, 

Rockville, MD 20857, 301–827–9363, 

FAX: 301–827–7101, e-mail: 

kimberly.pendleton@fda.hhs.gov. 

For more information on this funding 

opportunity announcement (FOA) and 

to obtain detailed requirements, please 

contact Kimberly Pendleton. 

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description 

[RFA–FD–10–008] 

[Catalog of Federal Domestic Assistance 

Number(s): 93.103 https://www.cfda.gov] 

A. Background 

The problem of counterfeit/falsified 

medicines was first addressed at the 

international level in 1985 at the 

Conference of Experts on the Rational 

Use of Drugs in Nairobi. The meeting 

recommended that the WHO and 

relevant stakeholders should study the 

feasibility of setting up a clearinghouse 

to collect data and to inform 

governments about the nature and 

extent of counterfeiting. This project 

represents a collaborative agreement 

between WHO and FDA in building 

global rapid alert surveillance/ 

monitoring system(s) for combating 

counterfeit/falsified medicines and risks 

in the supply chain security that will 

assist in developing the global 

landscape and identifying areas of 

public health risk, including such 

challenges and threats as diversion, 

intentional adulteration, and the 

increasing complexity and reduced 

transparency of the supply chain due to 

globalization and limited regulatory 

capacity (such as in resourceconstrained countries and/or countries 

where regulatory infrastructure lack 

robustness). 

B. Research Objectives 

• Support WHO technical 

cooperation with member states to 

attain better data and improve data 

sharing about the public health risks 

surrounding counterfeit/falsified 

medicine and supply chain security, 

through the development of surveillance 

and monitoring system(s) of counterfeit/ 

falsified medicines and risks in supply 

chains and rapid alert system(s). 

• This could include a phased-in 

approach for implementation, testing 

and assessment of a system, as well as 

subsequent refinements to the system 

based on assessments the WHO may 

consider relevant. 

• Support WHO’s work internally to 

identify and possibly adapt current 

global surveillance/monitoring systems 

that may exist in other programs (e.g., 

those that the industry uses to collect 

information on counterfeit/falsified 

medicines), as well as other public 

health areas (e.g., infectious diseases), 

and may be relevant in applicability to 

a surveillance/monitoring system for 

counterfeit/falsified medicines and 

supply chain integrity. 

• Work with member states 

strategically over time to establish the 

necessary processes, protocols and 

commitment to collect and contribute 

data, share/exchange data routinely and 

consistently, and use the data emanating 

from a surveillance and monitoring 

system for counterfeit/falsified 

medicines and supply chain risks in 

support of national, sub-regional and 

global strategies and decision-making to 

prevent and address the incidence of 

counterfeit/falsified medicines and risks 

within supply chains in a sustainable 

and measurable way. 

• Recognizing the importance of 

WHO’s Anti-counterfeiting Programme, 

support WHO’s contribution to the 

design, development and/or 

implementation of a global surveillance/ 

monitoring system to better address the 

challenges and risks of counterfeit/ 

falsified medicines and supply chain 

integrity. 

• Promote development of consistent 

terminology around counterfeit/falsified 

medicines to enable comparable data 

collection and analyses; standardized 

methods for data collection; and a 

harmonized approach to data analyses 

in support of populating and utilizing a 

global surveillance/monitoring system 

for counterfeit/falsified medicines and 

supply chain security. Work with 

Member States for the implementation 

of these methods at the country-level to 

enable successful and sustainable 

implementation of a global surveillance/ 

monitoring system to better address 

counterfeit/falsified medicines and 

supply chain integrity. 

• Recognizing that active 

commitment, participation and 

engagement of national medicine 

regulatory authorities in any WHO 

surveillance/monitoring system for 

counterfeit/falsified drugs is essential, 

WHO will need to work with Member 

States as appropriate, for 

implementation, assessment, and 

refinement of a surveillance/monitoring 

system for counterfeit/falsified drugs 

and supply chain integrity that is of 

utility to national medicine regulatory 

authorities and other relevant national 

government stakeholders. 

• Promote the development of peerreviewed published articles on the 

growing complexities and threats 

addressing counterfeit/falsified 

medicines and supply chain security 

with a goal to initiate dialogue and 

expand the thinking among 

policymakers and experts on ways to 

address this public health threat with a 

forward-look toward sustainable 

solutions through global collaboration 

and evidence-based approaches. 

C. Eligibility Information 

The following organizations/ 

institutions are eligible to apply: The 

World Health Organization. 

II. Award Information/Funds Available 

A. Award Amount 

FDA anticipates providing one award 

of $960,500 (total costs including 

indirect costs) in fiscal year (FY) 2010 

in support of this project. Subject to the 

availability of funds and successful 

performance, 3 additional years of 

support up to $847,500 per year will be 

available. 

B. Length of Support 

The support will be 1 year with the 

possibility of an additional three years 

of noncompetitive support. 

Continuation beyond the first year will 

be based on satisfactory performance 

during the preceding year, receipt of a 

non-competing continuation application 

and available Federal FY 

appropriations. 

Dated: October 6, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–25687 Filed 10–12–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Award of a Single-Source Expansion 

Supplement to the Research 

Foundation of CUNY on Behalf of 

Hunter College School of Social Work 

AGENCY: Children’s Bureau, ACYF, ACF, 

HHS. 

ACTION: Notice. 

CFDA Number: 93.556. 

Legislative Authority: Fostering 

Connections to Success and Increasing 

Adoptions Act of 2008 (Pub. L. 110– 

351). 

Amount of Award: $229,877. 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 197 / Wednesday, October 13, 2010 / Notices 62839 

Project Period: September 30, 2010 to 

September 29, 2011. 

SUMMARY: The Administration for 

Children and Families (ACF), Children’s 

Bureau (CB) announces the award of a 

single-source program expansion 

supplement to the Research Foundation 

of CUNY on behalf of Hunter College 

School of Social Work, New York, NY, 

to provide expanded technical 

assistance to address continuing 

challenges in the field as child welfare 

programs work to implement the 

requirements of new legislation. The 

Research Foundation of CUNY on behalf 

of Hunter College is the recipient of a 

cooperative agreement to act as the 

administrator for National Resource 

Center for Permanency and Family 

Connections (NRCPFC), which provides 

technical assistance services pursuant to 

the legislative authority of the 

Promoting Safe and Stable Families 

Amendments of the Social Security Act 

(42 U.S.C. 629e). 

The Fostering Connections to Success 

and Increasing Adoptions Act of 2008 

(Pub. L. 110–351) provides for a 

discretionary matching grant program to 

implement projects in the areas of 

Kinship Navigator, Family Finding, 

Family Group Decision Making, and 

Residential Family Treatment. The law 

also added a new plan requirement at 

§ 471(a)(29) that directs State foster care 

and adoption agencies (title IV–E 

agencies) to exercise due diligence to 

identify and notify all adult relatives of 

a child, within 30 days of the child’s 

removal, of the relative’s options to 

become a placement resource for the 

child. The supplemental funding will 

allow the NRCPFC to do the following: 

1. Provide focused technical 

assistance to Family Connections 

grantees. 

2. Engage States that did not receive 

discretionary grants in on-site 

consultation regarding effectively 

involving relatives in child welfare 

practice. 

3. Proactively transfer the knowledge 

developed under the discretionary grant 

program to States to assist in meeting 

new plan requirements. 

Under the proposed supplemental 

funding, the NRCPFC will increase 

technical assistance efforts to enhance 

the achievement of permanency by 

assisting agencies to better locate, notify 

and involve families and relatives in the 

engagement and planning process while 

maintaining awareness of 

confidentiality issues. 

FOR FURTHER INFORMATION CONTACT: Jane 

Morgan, Children’s Bureau, 1250 

Maryland Avenue, SW., Washington, 

DC 20024. Telephone: 202–205–8807; 

E-mail: jane.morgan@acf.hhs.gov. 

Dated: October 4, 2010. 

Bryan Samuels, 

Commissioner, Administration on Children, 

Youth and Families. 

[FR Doc. 2010–25713 Filed 10–12–10; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Award of a Single-Source Expansion 

Supplement to the Tribal Law and 

Policy Institute 

AGENCY: Children’s Bureau, ACYF, ACF, 

HHS. 

ACTION: Notice. 

CFDA Number: 93.658. 

Legislative Authority: Section 

476(c)(2)(iii) of the Social Security Act, 

as amended by the Fostering 

Connections to Success and Increasing 

Adoptions Act of 2008 (Pub. L. 110– 

351). 

Amount of Award: $400,000. 

Project Period: September 30, 2010 to 

September 29, 2011. 

SUMMARY: The Administration for 

Children and Families (ACF), Children’s 

Bureau (CB) announces the award of a 

single-source expansion supplement to 

the Tribal Law and Policy Institute, 

West Hollywood, CA, to provide more 

intensive technical assistance to Tribes. 

The Tribal Law and Policy Institute 

administers the National Resource 

Center for Tribes under a cooperative 

agreement where technical assistance is 

provided to Tribes to assist in building 

organizational capacity so that Tribes 

may operate their own foster care 

programs under title IV–E of the Social 

Security Act. Under the agreement, 

Tribal Law and Policy Institute 

identifies promising practices in Tribal 

child welfare systems, identifies and 

effectively implements community and 

culturally based strategies and resources 

that strengthen Tribal child and family 

services. 

The Fostering Connections to Success 

and Increasing Adoptions Act of 2008 

(the Act) was amended in 2008 by the 

addition of § 479B, which allows Indian 

Tribes the option to apply for Federal 

funding to support the administration of 

their own foster care, adoption 

assistance, and guardianship assistance 

programs under title IV–E of the Social 

Security Act (SSA). The Act was also 

amended at § 476(c)(2)(iii) to allow 

Indian Tribes to receive one-time 

development grants to be used to offset 

the cost of developing a title IV–E plan 

to carry out the requirements of § 479B. 

Supplemental funding will support 

Regional Roundtables and build Tribal 

capacity in the following areas: 

1. Development of a presentation on 

the Social Security Act and title IV–E 

provisions that provide foster care and 

adoption service funds. The 

presentation will be developed to be 

responsive to the cultural issues and 

needs of the Tribal audience. 

2. Training for Tribal caseworkers on 

title IV–E requirements in order to 

continue the eligibility and funding of 

IV–E eligible children. Caseworkers will 

be made aware of the provisions of 

Public Law 110–351 to insure that all 

appropriate services are provided to 

children in care. 

3. Assistance in the development of 

training for appropriate foster care 

recruitment, and retention so that 

placement of title IV–E eligible children 

will be made with licensed foster/kin 

families. Training will emphasize the 

linkages between for Tribal leaders, 

child welfare and court staff in the 

licensing and maintaining of title I–VE 

eligibility when children are placed in 

foster care. 

CONTACT FOR FURTHER INFORMATION: Jane 

Morgan, Children’s Bureau, 1250 

Maryland Avenue, SW., Washington, 

DC 20024. Telephone: 202–205–8807; 

E-mail: jane.morgan@acf.hhs.gov. 

Dated: October 4, 2010. 

Bryan Samuels, 

Commissioner, Administration on Children, 

Youth and Families. 

[FR Doc. 2010–25709 Filed 10–12–10; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration For Children And 

Families 

Award of a Single-Source Expansion 

Supplement to the Child Welfare 

League of America 

AGENCY: ACF, ACYF, HHS. 

ACTION: Notice. 

CFDA Number: 93.599. 

Legislative Authority: Section 

477(g)(2) of the Social Security Act. 

Amount of Award: $295,116. 

Project Period: September 30, 2010 to 

September 29, 2011. 

SUMMARY: The Administration for 

Children and Families (ACF), Children’s 

Bureau (CB), announces the award of a 

single-source expansion supplement to 

the Child Welfare League of America, 

Arlington, VA, to support the provision 

of intensive technical assistance to 

States. 

mstockstill on DSKH9S0YB1PROD with NOTICES